Cargando…
Complete Resolution of Sellar Metastasis in a Patient With NSCLC Treated With Osimertinib
Non–small cell lung cancer with pituitary metastasis (NSCLC-PM) is a devastating disease; however, treatment is being revolutionized by a novel therapy targeting highly specific tumor signals, such as the mutation of epidermal growth factor receptors (EGFRs). Long-term management of hormonal defects...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773432/ https://www.ncbi.nlm.nih.gov/pubmed/31592498 http://dx.doi.org/10.1210/js.2019-00217 |